(NDSN) Nordson - Overview

Sector: IndustrialsIndustry: Specialty Industrial Machinery | Exchange NASDAQ (USA) | Currency USD | Market Cap: 15.109m | Total Return 30.1% in 12m

Stock: Dispensing, Coating, Testing, Medical, Assembly

Total Rating 69

Risk 83

Buy Signal -0.75

Specialty Industrial Machinery -9.2
Industrial Machinery & Supplies & Components -6.0

Market Cap: 15,109m
Avg Trading Vol: 80.1M USD

ATR: 2.45%
Peers RS (IBD): 69.8

Risk 5d forecast
Volatility	24.4%
Relative Tail Risk	-10.6%

Reward TTM
Sharpe Ratio	0.94
Alpha	16.07

Character TTM
Beta	1.110
Beta Downside	1.406

Drawdowns 3y
Max DD	39.15%
CAGR/Max DD	0.21

EPS (Earnings per Share)

EPS CAGR: -0.66%
EPS Trend: 34.0%

Last SUE: 0.00
Qual. Beats: 0

Revenue

Rev. CAGR: 1.40%
Rev. Trend: 46.8%

Last SUE: 1.23
Qual. Beats: 1

Description: NDSN Nordson March 04, 2026

Nordson Corporation (NDSN) engineers and manufactures systems for dispensing and applying various fluids, coatings, and materials. The company operates in the industrial machinery sector, which produces and distributes equipment for manufacturing and other industrial processes.

Its Industrial Precision Solutions segment focuses on dispensing and coating systems for disposable products, roll goods, and automated adhesive applications. This segment also provides components for thermoplastic and biopolymer melt streams, fluid components, and control systems. The industrial machinery sector often serves diverse end markets, including packaging, automotive, and consumer goods.

The Medical and Fluid Solutions segment offers precision dispensers, plastic molded components, and interventional solutions for medical applications, including engineered shafts, medical tubing, and biomaterial delivery systems. The medical device industry, a key market for this segment, is characterized by stringent regulatory requirements and a focus on precision and reliability.

The Advanced Technology Solutions segment provides automated dispensing systems, gas plasma treatment systems, and destructive and non-destructive testing technologies for industries like semiconductors and printed circuit boards. The semiconductor industry, a primary customer for this segment, relies heavily on advanced manufacturing equipment for high-volume production.

Nordson distributes its products through a direct sales force, distributors, and sales representatives. For more in-depth analysis, consider exploring ValueRays comprehensive research tools.

Headlines to watch out for

Industrial Precision Solutions demand impacts revenue
Medical and Fluid Solutions growth drives profitability
Advanced Technology Solutions segment innovation boosts market share
Global manufacturing capital expenditure influences sales

Piotroski VR‑10 (Strict, 0-10) 8.5

Net Income: 523.2m TTM > 0 and > 6% of Revenue
FCF/TA: 0.11 > 0.02 and ΔFCF/TA 2.93 > 1.0
NWC/Revenue: 27.82% < 20% (prev 27.77%; Δ 0.05% < -1%)
CFO/TA 0.12 > 3% & CFO 700.5m > Net Income 523.2m
Net Debt (2.02b) to EBITDA (913.9m): 2.21 < 3
Current Ratio: 2.72 > 1.5 & < 3
Outstanding Shares: last quarter (56.1m) vs 12m ago -2.36% < -2%
Gross Margin: 55.17% > 18% (prev 0.55%; Δ 5.46k% > 0.5%)
Asset Turnover: 48.10% > 50% (prev 45.51%; Δ 2.59% > 0%)
Interest Coverage Ratio: 6.41 > 6 (EBITDA TTM 913.9m / Interest Expense TTM 119.2m)

Altman Z'' 6.01

A: 0.13 (Total Current Assets 1.25b - Total Current Liabilities 460.0m) / Total Assets 5.96b
B: 0.79 (Retained Earnings 4.69b / Total Assets 5.96b)
C: 0.13 (EBIT TTM 763.8m / Avg Total Assets 5.92b)
D: 1.63 (Book Value of Equity 4.64b / Total Liabilities 2.85b)
Altman-Z'' Score: 6.01 = AAA

Beneish M -3.00

DSRI: 1.01 (Receivables 571.6m/531.3m, Revenue 2.85b/2.67b)
GMI: 1.00 (GM 55.17% / 55.15%)
AQI: 1.01 (AQ_t 0.69 / AQ_t-1 0.68)
SGI: 1.06 (Revenue 2.85b / 2.67b)
TATA: -0.03 (NI 523.2m - CFO 700.5m) / TA 5.96b)
Beneish M-Score: -3.00 (Cap -4..+1) = A

What is the price of NDSN shares?

As of March 27, 2026, the stock is trading at USD 264.96 with a total of 221,238 shares traded.
Over the past week, the price has changed by -0.84%, over one month by -9.17%, over three months by +8.93% and over the past year by +30.07%.

Is NDSN a buy, sell or hold?

Nordson has received a consensus analysts rating of 4.20. Therefore, it is recommended to buy NDSN.

StrongBuy: 5
Buy: 2
Hold: 3
Sell: 0
StrongSell: 0

What are the forecasts/targets for the NDSN price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	307.4	16%
Analysts Target Price	307.4	16%

NDSN Fundamental Data Overview March 27, 2026

P/E Trailing = 29.3128
P/E Forward = 23.4742
P/S = 5.3094
P/B = 4.8549
P/EG = 1.8194
Revenue TTM = 2.85b USD
EBIT TTM = 763.8m USD
EBITDA TTM = 913.9m USD
Long Term Debt = 1.94b USD (from longTermDebt, last quarter)
Short Term Debt = 76.5m USD (from shortTermDebt, last quarter)
Debt = 2.14b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.02b USD (from netDebt column, last quarter)
Enterprise Value = 17.13b USD (15.11b + Debt 2.14b - CCE 120.4m)
Interest Coverage Ratio = 6.41 (Ebit TTM 763.8m / Interest Expense TTM 119.2m)
EV/FCF = 26.50x (Enterprise Value 17.13b / FCF TTM 646.3m)
FCF Yield = 3.77% (FCF TTM 646.3m / Enterprise Value 17.13b)
FCF Margin = 22.71% (FCF TTM 646.3m / Revenue TTM 2.85b)
Net Margin = 18.39% (Net Income TTM 523.2m / Revenue TTM 2.85b)
Gross Margin = 55.17% ((Revenue TTM 2.85b - Cost of Revenue TTM 1.28b) / Revenue TTM)
Gross Margin QoQ = 54.69% (prev 56.33%)
Tobins Q-Ratio = 2.87 (Enterprise Value 17.13b / Total Assets 5.96b)
Interest Expense / Debt = 1.25% (Interest Expense 26.8m / Debt 2.14b)
Taxrate = 18.92% (31.1m / 164.5m)
NOPAT = 619.3m (EBIT 763.8m * (1 - 18.92%))
Current Ratio = 2.72 (Total Current Assets 1.25b / Total Current Liabilities 460.0m)
Debt / Equity = 0.69 (Debt 2.14b / totalStockholderEquity, last quarter 3.11b)
Debt / EBITDA = 2.21 (Net Debt 2.02b / EBITDA 913.9m)
Debt / FCF = 3.13 (Net Debt 2.02b / FCF TTM 646.3m)
Total Stockholder Equity = 3.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.84% (Net Income 523.2m / Total Assets 5.96b)
RoE = 17.30% (Net Income TTM 523.2m / Total Stockholder Equity 3.02b)
RoCE = 15.38% (EBIT 763.8m / Capital Employed (Equity 3.02b + L.T.Debt 1.94b))
RoIC = 12.13% (NOPAT 619.3m / Invested Capital 5.11b)
WACC = 8.79% (E(15.11b)/V(17.25b) * Re(9.89%) + D(2.14b)/V(17.25b) * Rd(1.25%) * (1-Tc(0.19)))
Discount Rate = 9.89% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.29%
[DCF] Terminal Value 77.33% ; FCFF base≈573.7m ; Y1≈642.5m ; Y5≈854.9m
[DCF] Fair Price = 195.2 (EV 12.91b - Net Debt 2.02b = Equity 10.89b / Shares 55.8m; r=8.79% [WACC]; 5y FCF grow 13.88% → 3.0% )
EPS Correlation: 33.97 | EPS CAGR: -0.66% | SUE: 0.0 | # QB: 0
Revenue Correlation: 46.78 | Revenue CAGR: 1.40% | SUE: 1.23 | # QB: 1
EPS next Quarter (2026-04-30): EPS=2.82 | Chg7d=+0.006 | Chg30d=+0.089 | Revisions Net=+6 | Analysts=8
EPS current Year (2026-10-31): EPS=11.45 | Chg7d=+0.005 | Chg30d=+0.171 | Revisions Net=+9 | Growth EPS=+11.8% | Growth Revenue=+5.7%
EPS next Year (2027-10-31): EPS=12.37 | Chg7d=+0.037 | Chg30d=+0.236 | Revisions Net=+7 | Growth EPS=+8.1% | Growth Revenue=+4.9%
[Analyst] Revisions Ratio: +0.60 (8 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.5% (Discount Rate 9.9% - Earnings Yield 3.4%)
[Growth] Growth Spread = -0.0% (Analyst 6.4% - Implied 6.5%)

Additional Sources for NDSN Stock

Fund Manager Positions: Dataroma | Stockcircle